{
  "id": "clinical#risk_safety_aab7410d",
  "content": "cations, such as serotonin syndrome; parkinsonian hyperthermia syn-\ndrome following abrupt discontinuation of dopamine agonists; alcohol\nor sedative withdrawal; malignant hyperthermia occurring during\nanesthesia; hyperthermia associated with abuse of stimulants and hallu-\ncinogens; and atropine poisoning from anticholinergics.\nIn rare instances, individuals with schizophrenia or a mood disor-\nder may present with malignant catatonia, which may be indistin-\nguishable from neuroleptic malignant syndrome. Some investigators\nconsider neuroleptic malignant syndrome to be a drug-induced form of\nmalignant catatonia.\nMedication-Induced Acute Dystonia\n333.72 (G24.02) Medication-Induced Acute Dystonia\nAbnormal and prolonged contraction of the muscles of the eyes (oc-\nulogyric crisis), head, neck (torticollis or retrocollis), limbs, or trunk\ndeveloping within a few days of starting or raising the dosage of a\nmedication (such as a neuroleptic) or after reducing the dosage of a\nmedication used to treat extrapyramidal symptoms.\nMedication-Induced Acute Akathisia\n333.99 (G25.71) Medication-Induced Acute Akathisia\nSubjective complaints of restlessness, often accompanied by ob-\nserved excessive movements (e.g., fidgety movements of the legs,\nrocking from foot to foot, pacing, inability to sit or stand still), devel-\noping within a few weeks of starting or raising the dosage of a med-",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "medium",
    "topics": [
      "risk_safety",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Risk Safety cations, such as serotonin syndrome; parkinsonian hyperthermia syn-\ndrome following abrupt discontinuation of dopamine agonists; alcohol\nor sedative withdrawal; malignant hyperthermia occurring during\nanesthesia; hyperthermia associated with abuse of stimulants and hallu-\ncinogens; and atropine poisoning from anticholinergics.\nIn rare instances, individuals with schizophrenia or a mood disor-\nder may present with malignant catatonia, which may be indistin-\nguishable from neuroleptic malignant syndrome. Some investigators\nconsider neuroleptic malignant syndrome to be a drug-induced form of\nmalignant catatonia.\nMedication-Induced Acute Dystonia\n333.72 (G24.02) Medication-Induced Acute Dystonia\nAbnormal and prolonged contraction of the muscles of the eyes (oc-\nulogyric crisis), head, neck (torticollis or retrocollis), limbs, or trunk\ndeveloping within a few days of starting or raising the dosage of a\nmedication (such as a neuroleptic) or after reducing the dosage of a\nmedication used to treat extrapyramidal symptoms.\nMedication-Induced Acute Akathisia\n333.99 (G25.71) Medication-Induced Acute Akathisia\nSubjective complaints of restlessness, often accompanied by ob-\nserved excessive movements (e.g., fidgety movements of the legs,\nrocking from foot to foot, pacing, inability to sit or stand still), devel-\noping within a few weeks of starting or raising the dosage of a med- Cations, such as serotonin syndrome; parkinsonian hyperthermia syn-\ndrome following abrupt discontinuation of dopamine agonists; alcohol\nor sedative withdrawal; malignant hyperthermia occurring during\nanesthesia; hyperth..."
}